Method of Providing Aripiprazole to Patients Having Impaired CYP2D6 or CYP3A4 Enzyme Function
Otsuka Pharmaceutical Co., Ltd.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 14/034,727, filed Sep 24, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,980,803 | Method of Providing Aripiprazole to Patients Having Impaired CYP2D6 or CYP3A4 Enzyme Function In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 11,154,553 | Method of Providing Aripiprazole to Patients Having Impaired CYP2D6 or CYP3A4 Enzyme Function In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 11,344,547 | Method of Providing Aripiprazole to Patients Having Impaired CYP2D6 or CYP3A4 Enzyme Function In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 11,400,087 | Method of Providing Aripiprazole to Patients Having Impaired CYP2D6 or CYP3A4 Enzyme Function In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 10,525,057 | Method of Providing Aripiprazole to Patients Having Impaired CYP2D6 or CYP3A4 Enzyme Function In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | ||
| Application 17/206,241 | Method of Providing Aripiprazole to Patients Having Impaired CYP2D6 or CYP3A4 Enzyme Function Abandoned Abandoned Jul 19, 2023 | Otsuka Pharmaceutical Co., Ltd. | Abandoned | Abandoned Jul 19, 2023 | ||
| Application 17/731,494 | Method of Providing Aripiprazole to Patients Having Impaired CYP2D6 or CYP3A4 Enzyme Function Abandoned Abandoned Feb 24, 2025 | Otsuka Pharmaceutical Co., Ltd. | Abandoned | Abandoned Feb 24, 2025 | ||
| Application 19/053,509 | Method of Providing Aripiprazole to Patients Having Impaired CYP2D6 or CYP3A4 Enzyme Fuction Pending Not granted | Otsuka Pharmaceutical Co., Ltd. | Pending | Not granted |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Otsuka Pharmaceutical Co., Ltd..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.